Covered recipient · General Payments record
MARK H OLSEN
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2019–2025
$1,929.25
- Reported across 92 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.41 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Averitas Pharma Inc. | $144.66 | 9 |
| DJO, LLC | $51.06 | 2 |
| Paratek Pharmaceuticals, Inc. | $45.24 | 2 |
| Amgen Inc. | $33.76 | 2 |
| ORGANOGENESIS INC. | $21.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.01 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228277901 | CMS |
| Amgen Inc. | $18.75 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228277899 | CMS |
| Averitas Pharma Inc. | $26.60 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553294 | CMS |
| Averitas Pharma Inc. | $8.81 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553296 | CMS |
| Averitas Pharma Inc. | $19.23 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553298 | CMS |
| Averitas Pharma Inc. | $7.08 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553300 | CMS |
| Averitas Pharma Inc. | $8.38 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553302 | CMS |
| Averitas Pharma Inc. | $11.98 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553304 | CMS |
| Averitas Pharma Inc. | $34.42 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553306 | CMS |
| Averitas Pharma Inc. | $7.85 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553308 | CMS |
| Averitas Pharma Inc. | $20.31 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248553310 | CMS |
| DJO, LLC | $24.33 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1255068260 | CMS |
| DJO, LLC | $26.73 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1255068262 | CMS |
| Organogenesis Inc. | $21.69 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242030564 | CMS |
| Paratek Pharmaceuticals, Inc. | $23.24 | 05/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181758638 | CMS |
| Paratek Pharmaceuticals, Inc. | $22.00 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181758640 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.